172 related articles for article (PubMed ID: 37340151)
1. Modifiable risk factors for glioblastoma: a systematic review and meta-analysis.
Yoshikawa MH; Rabelo NN; Telles JPM; Figueiredo EG
Neurosurg Rev; 2023 Jun; 46(1):143. PubMed ID: 37340151
[TBL] [Abstract][Full Text] [Related]
2. Type 2 Diabetes Mellitus and Glioblastoma Multiforme-Assessing Risk and Survival: Results of a Large Retrospective Study and Systematic Review of the Literature.
Barami K; Lyon L; Conell C
World Neurosurg; 2017 Oct; 106():300-307. PubMed ID: 28698089
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs and glioma in the NIH-AARP Diet and Health Study cohort.
Daugherty SE; Moore SC; Pfeiffer RM; Inskip PD; Park Y; Hollenbeck A; Rajaraman P
Cancer Prev Res (Phila); 2011 Dec; 4(12):2027-34. PubMed ID: 21885814
[TBL] [Abstract][Full Text] [Related]
5. Clinical Risk and Overall Survival in Patients with Diabetes Mellitus, Hyperglycemia and Glioblastoma Multiforme. A Review of the Current Literature.
Montemurro N; Perrini P; Rapone B
Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33212778
[TBL] [Abstract][Full Text] [Related]
6. Case-control study of use of nonsteroidal antiinflammatory drugs and glioblastoma multiforme.
Sivak-Sears NR; Schwartzbaum JA; Miike R; Moghadassi M; Wrensch M
Am J Epidemiol; 2004 Jun; 159(12):1131-9. PubMed ID: 15191930
[TBL] [Abstract][Full Text] [Related]
7. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
JBI Libr Syst Rev; 2005; 3(6):1-33. PubMed ID: 27819973
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
9. Does diabetes decrease the risk of glioma? A systematic review and meta-analysis of observational studies.
Wang Y; Sun Y; Tang J; Zhou W; Liu X; Bi Y; Zhang ZJ
Ann Epidemiol; 2019 Feb; 30():22-29.e3. PubMed ID: 30545764
[TBL] [Abstract][Full Text] [Related]
10. The impact of body mass index and height on the risk for glioblastoma and other glioma subgroups: a large prospective cohort study.
Wiedmann MKH; Brunborg C; Di Ieva A; Lindemann K; Johannesen TB; Vatten L; Helseth E; Zwart JA
Neuro Oncol; 2017 Jul; 19(7):976-985. PubMed ID: 28040713
[TBL] [Abstract][Full Text] [Related]
11. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.
Konar SK; Bir SC; Maiti TK; Nanda A
J Neurosurg Pediatr; 2017 Feb; 19(2):239-248. PubMed ID: 27813458
[TBL] [Abstract][Full Text] [Related]
13. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
[TBL] [Abstract][Full Text] [Related]
14. Primary and metastatic glioblastoma of the spine in the pediatric population: a systematic review.
Yang R; Isaacs AM; Cadieux M; Hirmer TJ; CreveCoeur TS; Lapointe AP; Opoku-Darko M; Premji Z; Riva-Cambrin J; Gallagher CN
Childs Nerv Syst; 2021 Jun; 37(6):1849-1858. PubMed ID: 33675391
[TBL] [Abstract][Full Text] [Related]
15. Comparative epidemiology of gliosarcoma and glioblastoma and the impact of Race on overall survival: A systematic literature review.
Gerges C; Elder T; Penuela M; Rossetti N; Maynard M; Jeong S; Wright CH; Wright J; Zhou X; Burant C; Sajatovic M; Hodges T
Clin Neurol Neurosurg; 2020 Aug; 195():106054. PubMed ID: 32650210
[TBL] [Abstract][Full Text] [Related]
16. Active Immunotherapy for Glioblastoma Treatment: A Systematic Review and Meta-Analysis.
Wahyuhadi J; Immadoel Haq IB; Arifianto MR; Sulistyono B; Meizikri R; Rosada A; Sigit Prakoeswa CR; Susilo RI
Cancer Control; 2022; 29():10732748221079474. PubMed ID: 36748348
[TBL] [Abstract][Full Text] [Related]
17. Personal history of diabetes, genetic susceptibility to diabetes, and risk of brain glioma: a pooled analysis of observational studies.
Kitahara CM; Linet MS; Brenner AV; Wang SS; Melin BS; Wang Z; Inskip PD; Freeman LE; Braganza MZ; Carreón T; Feychting M; Gaziano JM; Peters U; Purdue MP; Ruder AM; Sesso HD; Shu XO; Waters MA; White E; Zheng W; Hoover RN; Fraumeni JF; Chatterjee N; Yeager M; Chanock SJ; Hartge P; Rajaraman P
Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):47-54. PubMed ID: 24220915
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic therapy for high-grade glioma.
Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778
[TBL] [Abstract][Full Text] [Related]
19. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
Kunkle B; Yoo C; Roy D
Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
[TBL] [Abstract][Full Text] [Related]
20. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma.
Pachocki CJ; Hol EM
J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
